Reference
Motokawa I, et al. A case of combined use of an angiotensin II receptor blocker and a calcium blocker to prevent recurrence of proteinuria, enabling continued bevacizumab treatment. Haigan / Japanese Journal of Lung Cancer 52: 897-901, No. 6, Oct 2012. Available from: URL: http://dx.doi.org/10.2482/haigan.52.897 [Japanese; summarised from a translation] - Japan
Rights and permissions
About this article
Cite this article
Bevacizumab. Reactions Weekly 1441, 11 (2013). https://doi.org/10.1007/s40278-013-1630-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-013-1630-3